Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
-regulatory network analysis approaches, developed and employed in the Malysheva Lab, are required to reveal these mechanisms. With the proposed project we aim to bridge this gap in our knowledge of cis
-
on cost-effectiveness, emission reduction, and social acceptability. D2ET will develop a comprehensive digital platform for planning energy transition scenarios, leveraging a consolidated data model and
-
decision-making for an optimal energy system, with specific focus on cost-effectiveness, emission reduction, and social acceptability. D2ET will develop a comprehensive digital platform for planning energy
-
campuses, benefits, strategic goals and your future colleagues. Would you like more information about EUTOPIA? Go to eutopia-university.eu , and read more about the role of the VUB in the development
-
. You will work on the cutting edge of both wind energy and machine learning, two of the fastest growing scientific disciplines, to develop machine learning surrogates of wind energy systems. As newer
-
) Theoretical knowledge will be further developed regarding the structure of transport governance, the importance of local residents’ quality of life and, ultimately, the transition of transport and urban
-
Learning Agreement is completely filled in and signed, dated and stamped where necessary! Language skills Your knowledge of Dutch and English. Please consult the language requirements in order to prepare the
-
for doctoral scholarship holders on the pay scales for Contract Research Staff . Opportunities of career development (doctoral training) A stimulating and international research environment You will receive
-
/immunotherapies are insufficient due to resistance development and limited efficacy. Personalized medicine, focusing on novel prognostic and predictive biomarkers to identify patients that will respond to treatment
-
malignancy and is the second leading cause of cancer-related deaths worldwide. Current treatment options such as chemotherapy and targeted/immunotherapies are insufficient due to resistance development and